Lupin launches generic Prograf

Lupin is introducing tacrolimus capsules in dosage strengths of 0.5 mg, 1 mg, and 5 mg.

The product is the generic of Astellas’ Prograf capsules.

It is indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant, liver transplant, and heart transplant, and in pediatric patients receiving allogeneic liver transplants, in combination with other immunosuppressants.

Tacrolimus capsules had a market value of approximately $303 million, according to September 2020 IQVIA data.